Nettetfor 1 dag siden · Le azioni di Intellia Therapeutics sono salite dopo che Canaccord Genuity ha iniziato la copertura con un rating buy (acquistare) MT. 13/04. Intellia Therapeutics, Inc.: Canaccord Genuity è per il Buy. MM. 07/04. Intellia Therapeutics, Inc.: RBC Capital Markets conferma il rating Buy. MM. Nettet22. jun. 2024 · At Intellia, he was responsible for working with the board of directors and executive committee in establishing and overseeing the implementation of Intellia’s strategic direction in both in vivo and ex vivo (engineered cell therapy) areas.
Intellia Therapeutics Names David Lebwohl, M.D., Chief
Nettet2. mai 2024 · Intellia Therapeutics Names Muna Bhanji, R.Ph., to its Board of Directors. May 02, 2024 16:01 ET Source: Intellia Therapeutics, Inc. CAMBRIDGE, Mass., May … Nettet2. mai 2024 · Intellia’s deep scientific, technical and clinical development experience, along with its robust intellectual property portfolio, have enabled the company to take a leadership role in harnessing ... microsoft stock price \u0026 dividend yield
John Leonard - Biography - MarketScreener.com
Nettet12 timer siden · 10 stocks we like better than Intellia Therapeutics When our analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock ... NettetAri Bousbib is chairman and chief executive officer of IQVIA. Mr. Bousbib assumed this position in October 2016 following the merger of Quintiles and IMS Health. From 2010 until the merger, he served as chairman and CEO of … Nettet23. feb. 2024 · Intellia’s deep scientific, technical and clinical development experience, along with its robust intellectual property portfolio, have enabled the company to take a leadership role in harnessing the full potential of genome editing to create new classes of genetic medicine. Learn more at intelliatx.com. Follow us on Twitter @intelliatx. microsoft stock prediction 2030